Results

Most recent

AMD-Non-neovascular

1–10 of 38 results for AMD-Non-neovascular

Impact of Baseline Imbalances on the Efficacy of Pegcetacoplan for the Treatment of GA: A Post Hoc Analysis of OAKS, DERBY, and FILLY
Sunir J. Garg, MD, FACS, FASRS
Updates from the Field
2022
Association of Ocular Antihypertensive Medications and the Development and Progression of Macular Degeneration in a US Insurance Claims Database
Thomas J Wubben, MD, PhD
On Demand Cases, Courses, and Papers
2020
Assessment of Progression of Geographic Atrophy in the FILLY Study
David R Lally, MD
On Demand Cases, Courses, and Papers
2020
Pentosan Polysulfate Maculopathy: Disease Course After Drug Cessation
Rachel Shah, MD
Annual Meeting Talks
2020
Nonneovascular Age Related Macular Degeneration and Fluid
David Sarraf, MD
Annual Meeting Talks
2020
Cognitive Testing in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
Subhransu K. Ray, MD, PhD
Annual Meeting Talks
2020
Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2020
Pentosan Polysulfate Maculopathy Versus Age-Related Macular Degeneration: Comparative Assessment With Multimodal Imaging
Joseph S Christiansen, MD
Annual Meeting Talks
2020
Phase 1 Safety Study of Intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a Novel Serine Protease Inhibitor, in Patients With GA
William Z. Bridges, MD
Annual Meeting Talks
2020
Ten-Year Follow-up Data From the AREDS2 Study
Emily Y. Chew, MD
Updates from the Field
2021